While SCFAs hold potential as a therapeutic agent for cancer, their use in clinical treatment is still under research. Some studies suggest that butyrate and other SCFAs can enhance the efficacy of certain chemotherapeutic agents and improve immune response. However, more clinical trials are needed to determine their effectiveness and safety in cancer treatment.
